I hope so, long ABUS from 2s and missed selling this morning pop up. ABUS may collect some money from that 20% sublicensing cut of its spinoff to BNTX mRNA products too.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.